Healthcare
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
Czech Republic-headquartered family office is targeting DACH and CEE region deals
CMA scrutiny of high-leverage PE divestment purchases expected to increase
PE could stand to lose its historic advantage with heightened regulatory baggage
Evoco expects portfolio acquisitions, assesses potential exits in 2H23
Switzerland-headquartered GP is currently deploying equity via its EUR 162m Evoco TSE III fund
GP Profile: Apheon builds on family roots, mulls exits and reinvestment opportunities
Belgian GP, formerly known as Ergon, to continue to target family- and entrepreneur-owned European businesses
Quadrivio to capitalise on baby boomers as it nears wrap for its new EUR 300m fund
The Silver Economy Fund makes its second investment as it highlights trend of GPs doubling down on narrow strategies
Corus Dental sponsors mandate Houlihan Lokey to review options
Upcoming process for Spain-based dental prosthetics company to launch in September
Eurazeo taps Rothschild for DORC exit
Upcoming process for Dutch medical equipment group expected to launch in September
Synlab remains in talks with Cinven five months after initial approach
Cinven listed lab diagnostics firm in April 2021 at EUR 18 per share and remains its largest shareholder
WestBridge raises GBP 130m in first close for third fund with debut deal in sight
UK-based PE firm has set GBP 200m hard-cap and target for the vehicle
Triton Partners exploring potential sale of Bormioli Pharma
Italian drug packaging company is likely to draw interest from strategics, plus sponsors with sector experience
EQT exits Schuelke to Athos-led consortium
The Munich-based family office has been an LP in EQT's funds; joined recent co-investment tickets
GP Profile: Baird Capital puts lower-middle-market niche and global expansion offering to work
GP’s flexible deal structure proposition resonates particularly well with founders in the current environment, Michael Holgate told Unquote
Bregal eyes local deal origination with new Swiss office
GP's third fund is completing its investment period, with fourth fund registered
Blatchford backer CBPE mandates Investec to oversee imminent exit
GP began weighing options for UK-based prosthetics manufacturer last July
Teasers out for Ardian-backed imes-icore
No formal process has kicked off for the German medtech firm but significant sponsor interest is expected
Apax acquires co-controlling stake in Fremman Capital-backed Palex Medical
Deal values Spain-headquartered medical equipment distributor at around EUR 1bn
Permira early strong contender in Triton-backed Pharmanovia auction
Speciality pharma business sale comes as a number of other large-cap healthcare auctions have faltered
PAI Partners nears close for EUR 7bn Fund VIII following timeline extension
France-headquartered firm is expected to close the vehicle in November 2023 amid a tough fundraising climate
Medicxi raises USD 400m to invest in single-focus life sciences companies
GP's fourth fund will deploy USD 10m-USD 20m tickets in narrow indications of unmet need; backed by pharma
Fremman considers return to market in 2024 following newly closed EUR 1bn debut fundraise
Pan-European GP raised its debut fund during the ‘most challenging’ period for debut funds in recent years
Stanley Capital Partners hires two in drive for growth
James Sexton and Frederik Fogtdal will join the mid-market healthcare and resource efficiency-focused GP as principal
KKA Partners boasts strong US LP showing in latest EUR 230m fund
Small mid-cap investor avoids pure tech businesses and ongoing ‘bubble’
Unquote Private Equity Podcast: In conversation with... Alex Walsh, Blackstone
Senior Managing Director Alex Walsh discusses topics including his career in the PE industry, LGBTQ+ representation and inclusion, and the current macro environment